CVE-2023-50345: Hcltech Dryice Myxalytics

Medium severity, CVSS 6.1. EPSS: 0.3% chance of exploitation in the next 30 days.

HCL DRYiCE MyXalytics is impacted by an Open Redirect vulnerability which could allow an attacker to redirect users to malicious sites, potentially leading to phishing attacks or other security threats.

Affected products

• Hcltech Dryice Myxalytics: version 5.9 only; version 6.0 only; version 6.1 only

Published 2024-01-03. Last modified 2026-06-17.